Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Big Cannabis Names ‘Not There Yet;' Long Path To Profitability Continues

By Investing.com (Brenda O'Farrell/Investing.com)Stock MarketsAug 10, 2021 05:47AM ET
www.investing.com/analysis/big-cannabis-names-not-there-yet-long-path-to-profitability-continues-200597507
Big Cannabis Names ‘Not There Yet;' Long Path To Profitability Continues
By Investing.com (Brenda O'Farrell/Investing.com)   |  Aug 10, 2021 05:47AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

Two of the big cannabis companies released their latest earnings this past Friday, and both pot growers saw revenues rise. But they failed to meet analysts’ expectations.

With these misses putting downward pressure on the stock prices of both Canopy Growth (NASDAQ:CGC) (TSX:WEED) and Cronos Group (NASDAQ:CRON) (TSX:CRON), investors may find themselves still wondering about each company's promised path to profitability. Indeed, investor sentiment is beginning to sound like that cranky toddler in the back seat of the family car asking: “Are we there yet?”

Canopy: Not Much Longer?

“We’re almost there. It won’t be much longer,” comes the answer from the ones in the drivers’ seat. Forced to be patient, however, does not make for smiles coming from anyone else who is along for the ride.

Shares of Canopy Growth held relatively steady on Monday, closing down only 0.2% on the day climbing back up after slipping in earlier trading.

CGC Weekly
CGC Weekly

On Friday, the Canadian-based marijuana grower that trades on the NASDAQ reported net revenues of C$136 million (USD$108.3M) in the first quarter that ended June 30. That was up 23% compared to the same period in the previous year. But the bottom line was the C$64-million loss (USD$50.9M) on an adjusted basis.

The other disappointment: the one-time largest cannabis company in the world also lost market share.

On the positive side, the large U.S. market continues to be a major focus for Canopy, and it is actively creating brand awareness, especially with its CBD products, and its partnerships, including with celebrity names like Martha Stewart.

In addition, it continues to be a leading industry innovator, producing a wide variety of products that fall into the cannabis 2.0 category of edibles, oils, and beverages that are aimed at a client base that is not your average pot smoker. But the downside is that many of these new products will not be available for sale until after the second quarter of 2022.

So, when will it reach profitability? The company’s answer was that it remained "committed" to "achieving positive adjusted EBITDA by end of fiscal 2022."

Following the release of the latest figures, a few Canadian analysts covering Canopy lowered their price targets on the stock. They included Canaccord Genuity, which dropped its price target to C$25 from C$30; CIBC lowered its price target to C$27 from C$30; Piper Sandler cut its price target to USD$19 from $24, while Stifel came with the lowest price of C$18, down from its previous mark of $21.

Canopy Growth closed on the Toronto Stock Exchange yesterday at $C24.03, $19.11 on the NASDAQ, down half a percentage in Canada, -0.21% in US trading on the day.

Cronos: Misses Mark In Q2, Too

Over at Cronos Group, meanwhile its second quarter earnings—also unveiled last Friday—showed sales jumped 58% to C$15.6 million (USD$12.4M). But that was well short of analysts’ forecasts of C$18.6 million ($USD14.8M).

As for its adjusted EBITDA, like Canopy, that came in at a loss. In this case a C$49.8-million loss (close to $40M USD).

CRON Weekly TTM
CRON Weekly TTM

Cronos shares dipped on Friday on the news, but have since regained some ground, although not all of it. The stock closed yesterday at $7.22 on the NASDAQ, down just over a percentage point on the day.

In the last year, Cronos shares are up about 29.5%. They are still well below the high they reached earlier this year, when they hit $12.26 in early February.

Big Cannabis Names ‘Not There Yet;' Long Path To Profitability Continues
 

Related Articles

Big Cannabis Names ‘Not There Yet;' Long Path To Profitability Continues

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (5)
jack black
jack black Aug 10, 2021 4:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Use Long Path Tool, Long Path Tool can simplify and probably end your problems in unlocking, managing and renaming files that appear to have a long filename.
Dark Secret
Dark Secret Aug 10, 2021 10:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
um... did you not see $CURLF earnings yesterday!? $312M, up $50M from last quarter. Really, you post this garbage a day over those numbers, and don't even acknowledge it?
Joseph Armour
Joseph Armour Aug 10, 2021 10:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So people, not actually involved in the day to day operation of this company or its product, make guesses as to how much these companies should make and its the company that failed, not the analysts. Let me ask this question. How often have any of you witnessed 'analysts' actually get their guesses right. Even a tenth of a point short of analysts guesses in earnings can cause a companies stock to drop. Yet, analysts guesses are all different and media not only averages these guesses but picks and chooses which ones they use and which they pretend don't exist. When are investors going to learn NOT to trust media.
Adam Theusch
Adam Theusch Aug 10, 2021 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Canada names shouldnt be the focus, they’re good at one thing… burning money
David Keller
David Keller Aug 10, 2021 8:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Not super surprised seeing these sub-par earnings, the real catalyst will come once the US Federal Gov legalizes cannabis, likely an agenda item for the Biden admin either before or after 2022 midterms...
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email